Enterovirus infections in young infants: are children still protected by maternal antibodies?

Liina Salur1, Sami Oikarinen, Sisko Tauriainen

  • 1Immunology Group, Institute of General and Molecular Pathology, University of Tartu, Tartu, Estonia.

Human Vaccines
|August 24, 2011
PubMed

Insights

Enterovirus infections are common in infants, with many lacking protective maternal antibodies. This study highlights the need for further research into the implications of these infections for infant health.

Area of Science:

  • Pediatrics
  • Virology
  • Immunology

Background:

  • Enterovirus infections are frequent in childhood and linked to chronic diseases like type 1 diabetes.
  • Maternal antibodies typically protect young infants, but declining enterovirus circulation may be reducing this effect.
  • The study investigates enterovirus infections in infants and the role of maternal antibodies.

Purpose of the Study:

  • To analyze the occurrence of enterovirus infections in 55 infants.
  • To assess the protective effect of maternal antibodies against enteroviruses.
  • To track the development of enterovirus antibodies in infants.

Main Methods:

  • Prospective cohort study involving 55 infants.
  • Detection of enteroviruses in fecal samples using reverse transcription-polymerase chain reaction (RT-PCR).
  • Serotype identification of enteroviruses via VP1 region sequencing.

Main Results:

  • Enterovirus RNA was detected in 12 of 194 fecal samples before polio vaccination (Coxsackieviruses A4, A5, A16; Echoviruses 13, 16).
  • Polio virus strains predominated after vaccination.
  • Maternal neutralizing antibody levels were generally high, but 3 out of 8 infants lacked antibodies against the enterovirus serotype found in their stool.

Conclusions:

  • Enterovirus infections are common in infants before 3 months of age.
  • A significant proportion of infants lack maternal antibodies against the enterovirus causing their infection.
  • The clinical significance of this lack of maternal antibody protection requires further investigation in larger studies.

Related Concept Videos

Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Vaccinations01:51

Vaccinations

Overview
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...